• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.

Co-authoring Researcher

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr
J-GLOBAL ID:201401060985631493   Update date: Apr. 07, 2025

Takeuchi Satoshi

Takeuchi Satoshi
Clips
Affiliation and department:
Research field  (1): Tumor diagnostics and therapeutics
Research theme for competitive and other funds  (2):
  • 2020 - 2023 Use of digital PET and deep learning for simultaneous quantification of tumor blood flow and metabolism from FDG PET
  • 2018 - 2021 Development of new therapeutic strategies for hypoxic tumors
Papers (44):
  • Naoto Wakabayashi, Shiro Watanabe, Satoshi Takeuchi, Takahiro Tsuchikawa, Yamato Munakata, Kenji Hirata, Rina Kimura, Junki Takenaka, Hiroshi Ishii, Kohsuke Kudo. Factors and predictors affecting late external dose rates and isolation period in patients after lutetium-177-labeled DOTA-Tyr3-octreotate treatment for neuroendocrine tumors. Annals of nuclear medicine. 2025
  • Junki Takenaka, Shiro Watanabe, Takashige Abe, Satoshi Takeuchi, Kenji Hirata, Rina Kimura, Hiroshi Ishii, Naoto Wakabayashi, Mungunkhuyag Majigsuren, Kohsuke Kudo. Urinary Dopamine Levels Can Predict the Avidity of Post-Therapy [131I]MIBG Scintigraphy in Unresectable or Metastatic Pheochromocytomas and Paragangliomas: A Preliminary Clinical Study. Pharmaceuticals. 2025. 18. 2. 165-165
  • 若林 直人, 渡邊 史郎, 竹内 啓, 土川 貴裕, 平田 健司, 木村 理奈, 竹中 淳規, 石井 宙史, 南部 敏和, 工藤 與亮. 神経内分泌腫瘍に対するLu-177 DOTATATE治療における投与翌日の体外線量率に影響を与える因子に関する検討. 核医学. 2024. 61. Suppl. S157-S157
  • 竹中 淳規, 渡邊 史郎, 安部 崇重, 土川 貴裕, 竹内 啓, 平田 健司, 木村 理奈, 石井 宙史, 若林 直人, 工藤 與亮. 切除不能/転移性PPGLにおけるMIBG治療前のFDG-PETの集積性に関する検討. 核医学. 2024. 61. Suppl. S169-S169
  • Satoshi Takeuchi, Kenji Hirata, Keiichi Magota, Shiro Watanabe, Rika Moku, Akihiko Shiiya, Jun Taguchi, Shin Ariga, Tomohiro Goda, Yoshihito Ohhara, et al. Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study. EJNMMI research. 2023. 13. 1. 69-69
more...
MISC (19):
more...
Education (1):
  • 2000 - 現在 Hokkaido University School of Medicine
Professional career (1):
  • 医学博士 (北海道大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page